Glaucoma News and Research

Latest Glaucoma News and Research

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

A joint research carried out by MIPT scientists and Harvard researchers have presented retinal cells that can integrate into the retina.

19 Apr 2021

Study finds that not all patients with elevated eye pressure need treatment to prevent vision loss

More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.

16 Apr 2021

New study provides the most comprehensive reviews of advancements in contact lenses

A newly-published paper represents one of the most comprehensive reviews of advancements to come in contact lenses, catapulting the commonly-used medical device to applications well beyond refractive error correction.

29 Mar 2021

Normal-tension glaucoma linked to increased risk of cognitive impairment

A type of glaucoma called normal-tension glaucoma is associated with an increased risk of cognitive impairment and possibly dementia, finds research published online in the British Journal of Ophthalmology.

27 Mar 2021

Study uncovers 50 new genes for eye color

The genetics of human eye color is much more complex than previously thought, according to a new study published today.

11 Mar 2021

New mobile app can help people diagnosed with glaucoma

Researchers from City, University London, supported by Allergan Pharmaceuticals and Glaucoma UK, have today released the latest edition of an app to help people newly diagnosed with glaucoma.

8 Mar 2021

Researchers identify drug target to fight Parkinson’s and Alzheimer’s disease

Neurodegenerative disorders such as Parkinson's and Alzheimer's disease are in the firing line after researchers identified an attractive therapeutic drug target.

3 Mar 2021

Yale researchers identify multiple genes involved in suppression of axon regeneration

When central nervous system cells in the brain and spine are damaged by disease or injury, they fail to regenerate, limiting the body's ability to recover.

2 Mar 2021

FDA permits marketing of new device to protect athletes from harmful effects of head impacts

Today, the U.S. Food and Drug Administration authorized marketing of a new device intended to be worn around the neck of athletes aged 13 years and older during sports activities to aid in the protection of the brain from the effects associated with repetitive sub-concussive head impacts.

26 Feb 2021

Smartphones could be used to reveal early-warning signs of glaucoma

Smartphones could be used to scan people's eyes for early-warning signs of glaucoma - helping to prevent severe ocular diseases and blindness, a new study reveals.

25 Feb 2021

FDA permits marketing of new prescription only device to reduce snoring and mild sleep apnea

Today, the U.S. Food and Drug Administration authorized marketing of a new prescription only device intended to reduce snoring and mild obstructive sleep apnea.

5 Feb 2021

Novel low molecular weight dextran-sulphate could play a key role in glaucoma treatment

Scientists at the University of Birmingham, UK, have shown that a novel low molecular weight dextran-sulphate, ILB® could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over 70 million people worldwide and causes irreversible blindness.

7 Jan 2021

Pioneering new eye test may predict wet AMD three years before symptoms develop

A pioneering new eye test, developed by scientists at UCL in collaboration with the Western Eye Hospital, London, may predict wet AMD, a leading cause of severe sight loss, three years before symptoms develop.

18 Dec 2020

Study offers new clues to the pathogenesis of glaucoma

In the search for new ways to treat the incurable eye disease glaucoma, researchers at Karolinska Institutet and St. Erik Eye Hospital in Sweden have discovered more clues as to its pathogenesis.

15 Dec 2020

New clue to protect neurons and encourage their growth found

Many neurodegenerative conditions, from glaucoma to Alzheimer's disease, are characterized by injury to axons -; the long, slender projections that conduct electrical impulses from one nerve cell to another, facilitating cellular communications. Injury to axons often leads to neuronal impairment and cell death.

14 Dec 2020

Researchers develop potential non-drug, non-surgical, long-acting therapy for glaucoma

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the eye.

7 Dec 2020

Researchers recommend strategies for improving the accuracy of polygenic risk scores

As the consumer genetics industry rapidly expands, more and more people are turning to DNA-based services to learn their risk of developing a wide range of diseases.

5 Dec 2020

Study: Global public health services fail to meet targets to reduce avoidable sight loss

A new global study has found no significant reduction in the number of people with treatable sight loss since 2010.

3 Dec 2020

Studies examine rates of blindness and vision impairment worldwide

Sobering new statistics released by the Global Burden of Disease study found no significant reduction in the number of people with treatable sight loss worldwide since 2010 as public health services failed to meet World Health Organization (WHO) targets.

2 Dec 2020

Financial symptoms could be used as early predictors of dementia

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the Federal Reserve Board of Governors found that Medicare beneficiaries who go on to be diagnosed with dementia are more likely to miss payments on bills as early as six years before a clinical diagnosis.

30 Nov 2020

Glaucoma News and Research

Latest Glaucoma News and Research

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

Study finds that not all patients with elevated eye pressure need treatment to prevent vision loss

New study provides the most comprehensive reviews of advancements in contact lenses

Normal-tension glaucoma linked to increased risk of cognitive impairment

Study uncovers 50 new genes for eye color

New mobile app can help people diagnosed with glaucoma

Researchers identify drug target to fight Parkinson’s and Alzheimer’s disease

Yale researchers identify multiple genes involved in suppression of axon regeneration

FDA permits marketing of new device to protect athletes from harmful effects of head impacts

Smartphones could be used to reveal early-warning signs of glaucoma

FDA permits marketing of new prescription only device to reduce snoring and mild sleep apnea

Novel low molecular weight dextran-sulphate could play a key role in glaucoma treatment

Pioneering new eye test may predict wet AMD three years before symptoms develop

Study offers new clues to the pathogenesis of glaucoma

New clue to protect neurons and encourage their growth found

Researchers develop potential non-drug, non-surgical, long-acting therapy for glaucoma

Researchers recommend strategies for improving the accuracy of polygenic risk scores

Study: Global public health services fail to meet targets to reduce avoidable sight loss

Studies examine rates of blindness and vision impairment worldwide

Financial symptoms could be used as early predictors of dementia

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Glaucoma News and Research

Latest Glaucoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in